Sex Differences in Injection Drug Risk Behaviors Among Hospitalized Persons

Objectives As opioid use increases, it remains important to assess factors that contribute to injection drug risk behaviors, as sharing needles and other drug use equipment contributes to the spread of human immunodeficiency virus and hepatitis C virus. Such risks may differ by sex and injecting with others. The current study examined factors that contribute to increased injection drug risk separately for men and women. Methods People who inject drugs were recruited at an academic safety-net hospital that reported recent injection drug use. Two main injection outcomes were assessed: (1) human immunodeficiency virus drug risk behaviors as assessed by the Risk Assessment Battery and (2) the number of times participants injected drugs with a needle used by someone else. For each outcome, different models for women and men were conducted to detect differences by sex. Results Both men and women were more likely to inject with a needle used by someone else if they used drugs within a sexual relationship (incidence rate ratio (IRR) = 14.61, P < 0.01; IRR = 7.17, P < 0.05). Being employed was associated with lower risk assessment battery scores among men, and lower mean rates of using a needle used by someone else among women (IRR = 0.22, P < 0.05). Women with post-traumatic stress disorder (PTSD) and men with higher depression scores had higher rates of injecting with a needle used by someone else. Conclusions People who inject drugs who are in intimate relationships report higher injection drug risk behaviors. We found benefits to employment among both men and women. Identifying factors associated with increased injection risk behaviors can be useful for creating interventions tailored by sex.

[1]  M. Stein,et al.  Skin Cleaning among Hospitalized Persons Who Inject Drugs: A randomized controlled trial. , 2020, Addiction.

[2]  N. Burke-Shyne,et al.  Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain , 2020, Harm Reduction Journal.

[3]  H. Surratt,et al.  Examining Factors Associated with Non-Fatal Overdose among People Who Inject Drugs in Rural Appalachia , 2020, Substance use & misuse.

[4]  Nancy L. Porteous,et al.  Applying gender-based analysis plus to Employee Assistance Programs: A Canadian perspective , 2020 .

[5]  O. Weiland,et al.  Significant decrease in injection risk behaviours among participants in a needle exchange programme , 2020, Infectious diseases.

[6]  Stephan Arndt,et al.  Employment recovery capital in the treatment of substance use disorders: Six-month follow-up observations. , 2019, Drug and alcohol dependence.

[7]  P. Holland,et al.  Role of boyfriends and intimate sexual partners in the initiation and maintenance of injecting drug use among women in coastal Kenya. , 2019, Addictive behaviors.

[8]  Laura J. Ball,et al.  Sharing of Injection Drug Preparation Equipment Is Associated With HIV Infection: A Cross-sectional Study , 2019, Journal of acquired immune deficiency syndromes.

[9]  R. Lechtenberg,et al.  Outbreak of Human Immunodeficiency Virus Infection Among Heterosexual Persons Who Are Living Homeless and Inject Drugs — Seattle, Washington, 2018 , 2019, MMWR. Morbidity and mortality weekly report.

[10]  S. Wakeman Harm Reduction Approaches for Opioid Use Disorder , 2019, Treating Opioid Addiction.

[11]  Y. Hser,et al.  Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial , 2018, Journal of Neuroimmune Pharmacology.

[12]  A. Moreland,et al.  Parenting outcomes of parenting interventions in integrated substance-use treatment programs: A systematic review. , 2018, Journal of substance abuse treatment.

[13]  Dawn E. Sugarman,et al.  Sex and gender differences in substance use disorders. , 2017, Clinical psychology review.

[14]  C. Reid,et al.  Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adults. , 2017, General hospital psychiatry.

[15]  S. Fraser,et al.  The intimate relationship as a site of social protection: Partnerships between people who inject drugs. , 2017, Social science & medicine.

[16]  F. Pampel,et al.  The Impact of Employee Assistance Services on Workplace Outcomes: Results of a Prospective, Quasi-Experimental Study , 2017, Journal of occupational health psychology.

[17]  S. Tregear,et al.  Prevalence of HIV Among U.S. Female Sex Workers: Systematic Review and Meta-analysis , 2016, Aids and Behavior.

[18]  S. Strathdee,et al.  Women Who Use or Inject Drugs: An Action Agenda for Women-Specific, Multilevel, and Combination HIV Prevention and Research , 2015, Journal of acquired immune deficiency syndromes.

[19]  E. Tuchman Women’s injection drug practices in their own words: a qualitative study , 2015, Harm Reduction Journal.

[20]  E. Tracy,et al.  Personal Network Recovery Enablers and Relapse Risks for Women With Substance Dependence , 2015, Qualitative health research.

[21]  S. Strathdee,et al.  Women, drugs and HIV. , 2015, The International journal on drug policy.

[22]  S. Soeker,et al.  The challenges that employees who abuse substances experience when returning to work after completion of employee assistance programme (EAP). , 2015, Work.

[23]  J. Montaner,et al.  Income level and drug related harm among people who use injection drugs in a Canadian setting. , 2014, The International journal on drug policy.

[24]  Jodi M. Jacobson,et al.  Employee assistance program services for alcohol and other drug problems: implications for increased identification and engagement in treatment. , 2012, The American journal on addictions.

[25]  N. El-Bassel,et al.  Dual HIV risk and vulnerabilities among women who use or inject drugs: no single prevention strategy is the answer , 2012, Current opinion in HIV and AIDS.

[26]  K. Brady,et al.  Comparative Profiles of Men and Women with Opioid Dependence: Results from a National Multisite Effectiveness Trial , 2011, The American journal of drug and alcohol abuse.

[27]  N. El-Bassel,et al.  Intimate Partner Violence and HIV Among Drug-Involved Women: Contexts Linking These Two Epidemics—Challenges and Implications for Prevention and Treatment , 2011, Substance use & misuse.

[28]  L. Palinkas,et al.  The perceived consequences of safer injection: An exploration of qualitative findings and gender differences , 2010, Psychology, health & medicine.

[29]  N. Freudenberg,et al.  Nowhere to go: How stigma limits the options of female drug users after release from jail , 2009, Substance abuse treatment, prevention, and policy.

[30]  L. Sheard,et al.  Contradictions and Misperceptions: An Exploration of Injecting Practice, Cleanliness, Risk, and Partnership in the Lives of Women Drug Users , 2008, Qualitative health research.

[31]  M. Pinquart,et al.  Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs). , 2008, Addiction.

[32]  C. Green,et al.  Substance abuse treatment entry, retention, and outcome in women: a review of the literature. , 2007, Drug and alcohol dependence.

[33]  L. Lundgren,et al.  Factors associated with HIV/AIDS high-risk behaviours among female injection drug users , 2007, AIDS care.

[34]  V. Slaymaker,et al.  Employed men and women substance abusers: job troubles and treatment outcomes. , 2006, Journal of substance abuse treatment.

[35]  A. Moss,et al.  Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO study) , 2003, Journal of Urban Health.

[36]  K. Hennigan,et al.  Outcomes for women with co-occurring disorders and trauma: program-level effects. , 2005, Journal of Substance Abuse Treatment.

[37]  Mark E. Johnson,et al.  Relationship among gender, depression, and needle sharing in a sample of injection drug users. , 2002, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[38]  R. Macrae,et al.  Gendered power dynamics and HIV risk in drug-using sexual relationships , 2000, AIDS care.

[39]  T. Rhodes,et al.  Drug users' sexual relationships and the social organisation of risk: the sexual relationship as a site of risk management. , 1998, Social science & medicine.

[40]  R. Drake,et al.  Review of integrated mental health and substance abuse treatment for patients with dual disorders. , 1998, Schizophrenia bulletin.

[41]  B Powis,et al.  The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. , 1995, Addiction.

[42]  G. Woody,et al.  Preparations for AIDS vaccine trials. An automated version of the Risk Assessment Battery (RAB): enhancing the assessment of risk behaviors. , 1994, AIDS research and human retroviruses.

[43]  G. Ottomanelli HIV Infection and Intravenous Drug Use , 1992 .